Clinical Trials Browser

Phase 2 × Head and Neck Neoplasms × tocilizumab × Clear all

NCT03708224 2025-01-28

Preoperative Immunotherapy in Patients With Squamous Cell Carcinoma of the Head and Neck

Phase 2 Recruiting

Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, Neoplasms